Mangoceuticals, Inc.Mangoceuticals, Inc.Mangoceuticals, Inc.

Mangoceuticals, Inc.

2,49USDC
−0,01−0,20%
Kapanışta Oca 3, 22:41 UTC
USD
İşlem yok
Süper-grafiklerde görün

MGRX temelleri

Gelir, giderler, kâr ve zarar dahil olmak üzere Mangoceuticals, Inc. mali tabloları

MGRX'nin son çeyrekteki toplam geliri 133.37 k USD ve önceki çeyreğe göre 18.26% daha düşük. Q3 24 döneminin net geliri -2.00 M USD'dur.

Q2 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−2,70 M‬‬
‪‪−1,80 M‬‬
‪‪−900,00 K‬‬
‪0,00‬
‪‪900,00 K‬‬
Toplam Gelir
Brüt Kar
Faaliyet gelirleri
Vergi öncesi gelir
Net gelir
Döviz: USD
Q2 '22
Haz 2022
Q4 '22
Ara 2022
Q1 '23
Mar 2023
Q2 '23
Haz 2023
Q3 '23
Eyl 2023
Q4 '23
Ara 2023
Q1 '24
Mar 2024
Q2 '24
Haz 2024
Q3 '24
Eyl 2024
TTM
Toplam GelirYY büyüme
‪‪8,94 K‬‬
‪‪100,72 K‬‬
‪‪141,24 K‬‬
‪‪245,16 K‬‬
‪‪244,37 K‬‬
+2.633,80%
‪‪214,09 K‬‬
+112,56%
‪‪163,16 K‬‬
+15,52%
‪‪133,37 K‬‬
−45,60%
‪‪755,00 K‬‬
‪‪−4,09 K‬‬
‪‪−43,52 K‬‬
‪‪−54,11 K‬‬
‪‪−100,57 K‬‬
‪‪−101,79 K‬‬
‪‪−66,70 K‬‬
‪‪−93,37 K‬‬
‪‪−50,70 K‬‬
‪‪−312,56 K‬‬
Brüt KarYY büyüme
‪‪4,85 K‬‬
‪‪57,20 K‬‬
‪‪87,13 K‬‬
‪‪144,59 K‬‬
‪‪142,58 K‬‬
+2.839,86%
‪‪147,40 K‬‬
+157,69%
‪‪69,79 K‬‬
−19,90%
‪‪82,67 K‬‬
−42,82%
‪‪442,44 K‬‬
‪‪−676,71 K‬‬
‪‪−2,62 M‬‬
‪‪−2,38 M‬‬
‪‪−1,94 M‬‬
‪‪−2,71 M‬‬
‪‪−2,52 M‬‬
‪‪−2,24 M‬‬
‪‪−1,84 M‬‬
‪‪−9,30 M‬‬
‪‪−671,86 K‬‬
‪‪−2,56 M‬‬
‪‪−2,29 M‬‬
‪‪−1,80 M‬‬
−448,78%
‪‪−2,57 M‬‬
−282,23%
‪‪−2,37 M‬‬
+7,48%
‪‪−2,17 M‬‬
+5,39%
‪‪−1,76 M‬‬
+2,30%
‪‪−8,86 M‬‬
‪‪−1,80 K‬‬
‪‪−1,76 K‬‬
‪‪8,23 K‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪‪−222,68 K‬‬
‪‪−241,62 K‬‬
‪‪−673,65 K‬‬
‪‪−2,56 M‬‬
‪‪−2,28 M‬‬
‪‪−1,80 M‬‬
−446,14%
‪‪−2,57 M‬‬
−281,21%
‪‪−2,37 M‬‬
+7,55%
‪‪−2,39 M‬‬
−4,70%
‪‪−2,00 M‬‬
−11,13%
‪‪−9,33 M‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪36,00‬
‪340,00‬
‪461,00‬
‪837,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪‪−673,65 K‬‬
‪‪−2,56 M‬‬
‪‪−2,28 M‬‬
‪‪−1,80 M‬‬
‪‪−2,57 M‬‬
‪‪−2,37 M‬‬
‪‪−2,39 M‬‬
‪‪−2,00 M‬‬
‪‪−9,33 M‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
Net gelirYY büyüme
‪‪−673,65 K‬‬
‪‪−2,56 M‬‬
‪‪−2,28 M‬‬
‪‪−1,80 M‬‬
−446,14%
‪‪−2,57 M‬‬
−281,21%
‪‪−2,37 M‬‬
+7,55%
‪‪−2,39 M‬‬
−4,68%
‪‪−2,00 M‬‬
−11,10%
‪‪−9,33 M‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪‪−673,65 K‬‬
‪‪−2,56 M‬‬
‪‪−2,28 M‬‬
‪‪−1,80 M‬‬
‪‪−2,57 M‬‬
‪‪−2,37 M‬‬
‪‪−2,39 M‬‬
‪‪−2,00 M‬‬
‪‪−9,33 M‬‬
‪−0,58‬
‪−3,41‬
‪−2,05‬
‪−1,70‬
−425,48%
‪−1,80‬
−208,16%
‪−1,56‬
+54,41%
‪−1,37‬
+32,96%
‪−0,99‬
+41,44%
‪−5,72‬
‪−0,58‬
‪−3,41‬
‪−2,05‬
‪−1,70‬
−425,48%
‪−1,80‬
−208,16%
‪−1,56‬
+54,41%
‪−1,37‬
+32,96%
‪−0,99‬
+41,44%
‪−5,72‬
‪‪1,15 M‬‬
‪‪750,56 K‬‬
‪‪1,11 M‬‬
‪‪1,06 M‬‬
‪‪1,43 M‬‬
‪‪1,52 M‬‬
‪‪1,74 M‬‬
‪‪2,01 M‬‬
‪‪1,15 M‬‬
‪‪750,56 K‬‬
‪‪1,11 M‬‬
‪‪1,06 M‬‬
‪‪1,43 M‬‬
‪‪1,52 M‬‬
‪‪1,74 M‬‬
‪‪2,01 M‬‬
FAVÖKYY büyüme
‪‪−668,00 K‬‬
‪‪−2,55 M‬‬
‪‪−2,29 M‬‬
‪‪−1,79 M‬‬
−446,86%
‪‪−2,56 M‬‬
−283,50%
‪‪−2,36 M‬‬
+7,51%
‪‪−2,17 M‬‬
+5,28%
‪‪−1,71 M‬‬
+4,44%
‪‪−8,80 M‬‬
FVÖKYY büyüme
‪‪−671,86 K‬‬
‪‪−2,56 M‬‬
‪‪−2,29 M‬‬
‪‪−1,80 M‬‬
−448,78%
‪‪−2,57 M‬‬
−282,23%
‪‪−2,37 M‬‬
+7,48%
‪‪−2,17 M‬‬
+5,39%
‪‪−1,76 M‬‬
+2,30%
‪‪−8,86 M‬‬
‪‪−680,79 K‬‬
‪‪−2,66 M‬‬
‪‪−2,43 M‬‬
‪‪−2,04 M‬‬
‪‪−2,81 M‬‬
‪‪−2,58 M‬‬
‪‪−2,33 M‬‬
‪‪−1,89 M‬‬
‪‪−9,62 M‬‬